Showing results (161-170 of 206) with videos related to
Sort By:
Pageof 21
Biochemical and Biophysical Research Communications|April 8, 2006
Immune-mediated beta-cell destruction in vitro and in vivo-A pivotal role for galectin-3Allan E Karlsen, Zenia M Størling, Thomas Sparre, et al.BMC Medicine|November 4, 2020
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWASTill F M Andlauer, Jenny Link, Dorothea Martin, et al.Cell Reports|July 27, 2017
Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated ImmunoevasionPaolo Romania, Loredana Cifaldi, Benedetta Pignoloni, et al.Iscience|December 2, 2024
Corroborating written history with ancient DNA: The case of the Well-man described in an Old Norse <i>saga</i>Martin R Ellegaard, S Sunna Ebenesersdóttir, Kristjan H S Moore, et al.International Journal of Molecular Sciences|August 26, 2023
DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and MonocytesAlexandre Xavier, Vicki E Maltby, Ewoud Ewing, et al.Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis riskKatarina Tengvall, Jesse Huang, Cecilia Hellström, et al.Plos One|June 21, 2013
Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patientsMaurizio A Leone, Nadia Barizzone, Federica Esposito, et al.European Journal of Human Genetics : EJHG|November 6, 2009
A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosisInger-Lise Mero, Aslaug R Lorentzen, Maria Ban, et al.The Journal of Clinical Investigation|November 15, 2019
C-type lectin receptors Mcl and Mincle control development of multiple sclerosis-like neuroinflammationMarie N'diaye, Susanna Brauner, Sevasti Flytzani, et al.Journal of Neurology|September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.Pageof 21